🔎 Trials Near Me

Home › Diffuse Large B-Cell Lymphoma › Indiana › Indianapolis

Diffuse Large B-Cell Lymphoma clinical trials in Indianapolis, IN

7 studies for Diffuse Large B-Cell Lymphoma are looking for participants at sites in and around Indianapolis (within about 30 miles). Open a study to see who can join and how to contact the study team.

Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma

RecruitingPhase 2
  • Saint Catherine Hospital, Indianapolis
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT06649812

A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma

RecruitingPhase 3
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
  • St Vincent Ascension at Peyton Manning Childrens Hospital, Indianapolis
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06091865

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

RecruitingPhase 2
  • IU Simon Comprehensive Cancer Center, Indianapolis
  • Indiana Blood and Marrow Transplantation, Indianapolis
Ages 18 and older · All sexes · Updated Aug 31, 2026 · NCT06500273

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

RecruitingPhase 1/2
  • Indiana Blood and Marrow Transplantation, Indianapolis
Ages 18 and older · All sexes · Updated Aug 25, 2026 · NCT05826535

Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell Lymphoma

RecruitingPhase 2
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
Ages 18 and older · All sexes · Updated Jul 10, 2026 · NCT05852717

Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment

RecruitingPhase 2
  • Saint Catherine Hospital, Indianapolis
Ages 18 and older · All sexes · Updated Oct 20, 2025 · NCT05890352

DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

RecruitingPhase 2
  • Indiana University Health Melvin and Bren Simon Cancer Center, Indianapolis
Ages 18 and older · All sexes · Updated Apr 7, 2023 · NCT04920617

Diffuse Large B-Cell Lymphoma trials in other cities

Other studies in Indianapolis

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.